LOS ANGELES, CA / ACCESSWIRE / September 13, 2018 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 16 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, ...

DECN Receives "No Comment" Letter from SEC, Providing Ability, Upon Formal Qualification, to Raise Up to $7.5 Million in Financing Under Regulation A LOS ANGELES, CA / ACCESSWIRE / September 6, 2018 / ...

Company Adding A Low End System For Sale On Amazon, Walmart & Other Sites, While Second System With A Multi-Patient Monitor Is Perfect For Nursing Homes & Clinics DECN announces today that we have ...

Company's Confidence Grows On The Back Of Recent Rulings And Court Room Events Strengthening An Already Strong Case With Huge Settlement Potential Much of the misinformation and several of the rulings ...

Keith Berman, the CEO of Decision Diagnostics Corporation (DECN), was indicted for securities fraud after investors purchased stock in his company hoping to profit from a revolutionary COVID-19 test ...

FDA Commissioner Dr. Stephen Hahn says, "These types of tests will be a game changer" LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics ...

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Decision Diagnostics Corp. (OTC: ...

Short interest in Decision Diagnostics Corp (OTC:DECN) decreased during the last reporting period, falling from 100.00 to 100.00. This put -% of the company's publicly available shares short. Short ...

Decision Diagnostics Corp. (DECN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

At close: 5 June at 20:00:00 GMT-4 ...